Cluster Pharma India Private Limited
About Cluster Pharma India Private Limited
Data last updated:
Cluster Pharma India Private Limited is a private limited company based in Dindigul, Tamil Nadu, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 16 August 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U24232TZ2007PTC013880. Its GSTIN is 33AADCC1537C1ZC (Tamil Nadu).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.9 Lakh. It is led by directors Rajaram Kannan and Ramalingam Ravindran.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 39/12 – A First Floor Society Street, Dindigul, Tamil Nadu, India – 624001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.98 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹3.69 Lakh (net margin 1.9%) and EBITDA of ₹5.13 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cluster Pharma India Private Limited's registered office is in Dindigul, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address39/12 – A First Floor Society Street, Dindigul, Tamil Nadu, India – 624001
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Cluster Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cluster Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cluster Pharma India Private Limited, buy the company report.
Financials of Cluster Pharma India Private Limited
FY 2025 filings availableCluster Pharma India Private Limited reported revenue of ₹1.98 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 7% growth in the latest year. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cluster Pharma India Private Limited, buy the company report.
Board of directors of Cluster Pharma India Private Limited
Cluster Pharma India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajaram Kannan | Director | 16 Aug 2007 | 19 Years 2 Months | Current |
| Ramalingam Ravindran | Director | 16 Aug 2007 | 19 Years 2 Months | Current |
Shareholding
The shareholding of Cluster Pharma India Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Cluster Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cluster Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cluster Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cluster Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCC1537C1ZC | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cluster Pharma India Private Limited, buy the company report.
Recent activity
Cluster Pharma India Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Bangarusamy Radhakrishnan ceased to be Director on 05 Mar 2019.
Frequently asked questions
Cluster Pharma India is an active private limited company based in Dindigul, Tamil Nadu, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 16 August 2007 (19+ years old) and is registered under CIN U24232TZ2007PTC013880.
Cluster Pharma India has 2 current directors:
- Rajaram Kannan - Director
- Ramalingam Ravindran - Director
The latest financial statements of Cluster Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cluster Pharma India is 33AADCC1537C1ZC, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Cluster Pharma India is U24232TZ2007PTC013880. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cluster Pharma India was incorporated on 16 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Coimbatore.
Bangarusamy Radhakrishnan ceased to be Director on 05 Mar 2019. Rajaram Kannan was appointed as Director on 16 Aug 2007. Ramalingam Ravindran was appointed as Director on 16 Aug 2007.
The registered office of Cluster Pharma India is at 3912 – A First Floor Society Street, Dindigul, Tamil Nadu, India – 624001.
Cluster Pharma India operates in the healthcare industry, in the medical consumables and supplies segment.
The compliance status of Cluster Pharma India is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.